,,ii  #aaith ,,congress  #b;d ,session  
,s4 #djff  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,march #aa1    
#bjbf,mr4 ,hawley introduced the        
following bill2 which was read twice and
 referred to the ,committee on ,health1 
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to provide that the approved   
application under the ,federal ,food1   
,drug1 and ,cosmetic ,act for the drug  
mifepristone for the purpose of the     
termination of intrauterine pregnancy is
 deemed to have been withdrawn1 to      
establish a ,federal tort for harm to   
women caused by chemical abortion drugs1
 and for other purposes4  #a4 ,short    
title ,this ,act may be cited as the    
,safeguarding ,women from ,chemical     
,abortion ,act4  #b4 ,withdrawal of     
approval of the drug mifepristone for   
termination of pregnancy ,effective upon
 the expiration of #ad days after the   
date of the enactment of this ,act3 7#a7
 ,approval of an application submitted  
under subsection 7b7 of section #eje of 

the ,federal ,food1 ,drug1 and ,cosmetic
 ,act 7#ba ,u4,s4,c4 #cee7 for the drug 
mifepristone 7marketed as ,mifeprex1 and
 also known as ,,ru-#dhf7 with an       
indication for the termination of       
intrauterine pregnancy1 and of any      
application submitted under subsection  
7j7 of such section for a drug with the 
same indication and for which           
mifepristone is the reference drug1 is  
deemed to have been withdrawn under     
subsection 7e7 of such section4  7#b7   
,for purposes of sections #cja7;d7 and  
#cjd of the ,federal ,food1 ,drug1 and  
,cosmetic ,act 7#ba ,u4,s4,c4 #cca7;d72 
#ccd71 the introduction or delivery for 
introduction of a drug1 the approval of 
which has been withdrawn as described in
 paragraph 7#a71 into interstate        
commerce shall be considered a violation
 of section #eje of such ,act 7#ba      
,u4,s4,c4 #cee74  7#c7 ,the drug        
mifepristone shall be considered        
misbranded for purposes of sections #cja
 and #cjd of the ,federal ,food1 ,drug1 

and ,cosmetic ,act 7#ba ,u4,s4,c4 #cca2 
#ccd7 if the drug bears labeling        
providing that the drug may be used for 
the termination of intrauterine         
pregnancy or that the drug may be used  
in conjunction with another drug for the
 termination of intrauterine pregnancy4 
#c4 ,federal tort for harm to women     
caused by chemical abortion drugs  7a7  
,definitions ,in this section3 7#a7     
,covered entity ,the term covered entity
 means a person that manufactures a     
covered medication for introduction into
 interstate commerce4  7#b7 ,covered    
medication ,the term covered medication 
means the drug mifepristone 7marketed as
 ,mifeprex1 and also known as           
,,ru-#dhf71 with an indication for the  
termination of intrauterine pregnancy1  
approved pursuant to an application     
submitted under subsection 7b7 or 7j7 of
 section #eje of the ,federal ,food1    
,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4
 #cee74  7b7 ,liability ,a covered      
entity shall be liable in accordance    

with this section to any individual who 
suffers bodily injury or harm to mental 
health 7including any physical1         
psychological1 emotional1 or            
physiological harm7 that is             
attributable1 in whole or in part1 to   
the individual's use of a covered       
medication manufactured by a covered    
entity4  7c7 ,private right of action   
,an individual who suffers bodily injury
 or harm to mental health that is       
attributable1 in whole or in part1 to   
the individual's use of a covered       
medication as described in subsection   
7b7 may bring a civil action against the
 covered entity in an appropriate       
district court of the ,united ,states or
 a ,state court of competent            
jurisdiction for-- 7#a7 compensatory    
damages2  7#b7 punitive damages2 and    
7#c7 attorney's fees and costs4  7d7    
,rules of construction ,nothing in this 
section shall be construed to preempt   
any ,state law that makes available any 
other remedy to an individual described 

in subsection 7b74  7e7 ,effective date 
,this section shall take effect on the  
date that is #ij days after the date of 
enactment of this ,act4  #d4 ,rule of   
construction ,nothing in this ,act shall
 be construed to affect any provision of
 section #adfa of title #ah1 ,united    
,states ,code4